By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Spectrum Pharmaceuticals, Inc. 

157 Technology Drive

Irvine  California  92618  U.S.A.
Phone: 949-788-6700 Fax: 949-788-6706




Company News
Spectrum Pharmaceuticals, Inc. (SPPI) Commits To Review Shareholder Proposal 5/14/2015 12:55:15 PM
Spectrum Pharmaceuticals, Inc. (SPPI) Announces First Quarter 2015 Financial Results Teleconference and Webcast 4/30/2015 12:37:02 PM
Spectrum Pharmaceuticals, Inc. (SPPI) Selects DSG For Blended Saas And Tech Transfer EDC 4/29/2015 10:58:57 AM
Four Oncology Key Opinion Leaders To Present At Spectrum Pharmaceuticals, Inc. (SPPI)’ Analyst Day On Friday, March 13th 3/11/2015 11:00:43 AM
Spectrum Pharmaceuticals, Inc. (SPPI) Announces FDA's Acceptance Of NDA Filing For Captisol-Enabled (Propylene Glycol-Free) Melphalan 3/9/2015 11:29:22 AM
Spectrum Pharmaceuticals, Inc. (SPPI) In-Licenses Poziotinib, A Novel pan-HER Inhibitor With Clinical Activity In Several Solid Tumors, From Hanmi Pharmaceutical, Co., Ltd 3/4/2015 11:00:53 AM
Spectrum Pharmaceuticals, Inc. (SPPI)To Present Corporate Update At The 2015 RBC Capital Markets' Global Healthcare Conference On February 24th 2/20/2015 11:14:46 AM
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Fourth Quarter 2014 Financial Results And Analyst Day 2/17/2015 10:36:41 AM
Spectrum Pharmaceuticals, Inc. (SPPI) Highlights Clinical Data For Captisol-Enabled (Propylene Glycol-Free) Melphalan At The 2015 BMT Tandem Meeting 2/12/2015 12:00:40 PM
Ligand Pharmaceuticals Inc. (LGND) Partner Spectrum Pharmaceuticals, Inc. (SPPI) Announces Submission Of New Drug Application For Captisol-Enabled™ Melphalan 12/29/2014 9:30:05 AM